Soliton News - SOLY

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Soliton Inc SOLY NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 10.32 10.46 10.15 10.31 10.32 23:59:46
more quote information »

Recent News

Date Time Source Heading
12/10/201908:00PRNUSSoliton Appoints Mary Stoll as Senior Director of Clinical..
12/03/201908:00PRNUSSoliton Initiates Significant Step Towards Commercialization
11/25/201906:03EDGARNotice of Effectiveness (effect)
11/22/201916:05EDGARCurrent Report Filing (8-k)
11/21/201908:00PRNUSSoliton and Emphysys Enter Into a 3-year Development..
11/12/201908:00PRNUSSoliton Announces First Follow-up Visit Conducted in the..
11/08/201916:13EDGARSecurities Registration Statement (s-1)
11/07/201916:30EDGARQuarterly Report (10-q)
11/05/201909:00PRNUSSoliton Completes Treatment of All Patients in Pivotal..
10/29/201908:00PRNUSSoliton's Recent Positive Data Increases Potential Fibrotic..
10/25/201908:00PRNUSSoliton Announces Positive Interim Clinical Trial Results..
10/21/201908:00PRNUSSoliton to Announce Keloid Trial Data on October 25, 2019..
10/16/201906:02EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
10/15/201918:09EDGARStatement of Changes in Beneficial Ownership (4)
10/15/201916:15EDGARCurrent Report Filing (8-k)
10/15/201908:00PRNUSSoliton's FDA Cleared RAP Device is Granted Two Additional..
10/10/201908:30PRNUSSoliton Announces $6.25 Million Private Placement
10/08/201908:00PRNUSSoliton to Announce Keloid and Hypertrophic Scar Clinical..
10/03/201908:00PRNUSSoliton Announces Tattoo Technology Article Published in..
10/01/201908:00PRNUSSoliton Completes Keloid POC Clinical Trial Treatments
9/24/201908:00PRNUSSoliton Announces Majority of Patients Treated in Pivotal..
9/19/201916:16EDGARCurrent Report Filing (8-k)
9/19/201908:45PRNUSSoliton Begins Treatments In Proof-Of-Concept Trial For..
9/17/201908:00PRNUSSoliton Completes Trial Enrollment and Conducts Initial Site..
9/10/201908:00PRNUSSoliton Announces Site Selected for Clinical Trial to Treat..
9/09/201908:32EDGARCurrent Report Filing (8-k)
9/09/201908:00PRNUSSoliton Releases Letter to Shareholders
9/04/201908:00PRNUSSoliton Announces IRB Approval for Keloid Trial
8/29/201908:00PRNUSSoliton to Initiate POC Clinical Trials to Treat Fibrotic..
8/26/201917:02EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/26/201908:00PRNUSSoliton Engages argodesign in Preparation of Commercial..
8/26/201906:00EDGARNotice of Effectiveness (effect)
8/20/201908:00PRNUSSoliton Announces Positive Results Demonstrated from Longer..
8/16/201908:00PRNUSDr. Michael Kaminer Presented Soliton RAP for Cellulite at..
8/14/201908:00PRNUSSoliton Treats First Patients in Pivotal Cellulite Trial
8/12/201908:00PRNUSSoliton Announces Patient Recruitment Has Begun for Pivotal..
8/09/201917:12EDGARQuarterly Report (10-q)
8/06/201917:03EDGARSecurities Registration Statement (s-1/a)
8/06/201908:00PRNUSSoliton Completes Site Enrollment and Conducts Initial Site..
8/05/201908:00PRNUSSoliton Partners with Clear Dermatology and Aesthetics..
8/01/201909:28PRNUSSoliton Announces Global Nasdaq Partner Sanmina Delivers RAP..
7/29/201908:00PRNUSSoliton Announces IRB Approval
7/25/201908:00PRNUSSoliton Enlists Chicago Cosmetic Surgery and Dermatology to..
7/23/201908:00PRNUSSoliton's FDA Cleared Device is Granted Key Patent
7/16/201908:00PRNUSSoliton Announces Submission for IRB Approval of Pivotal..
7/15/201917:01EDGARCurrent Report Filing (8-k)
7/15/201908:00PRNUSSoliton Announces Positive 26-week Cellulite Clinical Trial..
7/12/201917:02EDGARSecurities Registration: Employee Benefit Plan (s-8)
7/10/201908:00PRNUSSoliton Expands Clinical Trial Sites to include SkinCare..
7/08/201908:00PRNUSSoliton to Announce Cellulite Trial Data for 26-Week Period..
See more news about this stock »
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191214 19:15:41